Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PHD and RING finger domain-containing protein 1 (PHRF1) is a multi-domain nuclear protein characterized by its possession of a PHD finger, a motif that recognizes methylated histone H3 (notably H3K36me2 and H3K36me3), and a RING finger, mediating E3 ubiquitin ligase activity[3][1]. PHRF1 participates in chromatin biology including transcriptional regulation, DNA damage response through non-homologous end joining, and protein ubiquitination (notably of PARP1 and TGIF), contributing to genome integrity and cellular responses to genotoxic stress[1][3][5]. It is associated with transcriptional regulation via interactions with RNA polymerase II, splicing factors, and chromatin marks, and shown to regulate cell cycle checkpoint control and splicing-associated genes[1]. Overexpression or aberrant function of PHRF1 has been implicated in multiple cancers, in part owing to its contribution to DNA repair, chromatin dynamics, and suppression of tumorigenic signaling pathways[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PHD and RING finger domain-containing protein 1 (PHRF1).